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Abstract
PRDM family members are transcriptional regulators involved in tissue specific differentiation. PRDM5 has been reported to
predominantly repress transcription, but a characterization of its molecular functions in a relevant biological context is lacking.
We demonstrate here that Prdm5 is highly expressed in developing bones; and, by genome-wide mapping of Prdm5 occupancy
in pre-osteoblastic cells, we uncover a novel and unique role for Prdm5 in targeting all mouse collagen genes as well as several
SLRP proteoglycan genes. In particular, we show that Prdm5 controls both Collagen I transcription and fibrillogenesis by
binding inside the Col1a1 gene body and maintaining RNA polymerase II occupancy. In vivo, Prdm5 loss results in delayed
ossification involving a pronounced impairment in the assembly of fibrillar collagens. Collectively, our results define a novel role
for Prdm5 in sustaining the transcriptional program necessary to the proper assembly of osteoblastic extracellular matrix.
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Introduction
PRDM proteins constitute a family of transcriptional regulators
characterized by the presence of a N-terminal PR- domain that
shares 20–30% similarity to the SET domain of histone
methyltransferases and a variable number of zinc-finger domains
typically involved in protein-DNA or protein-protein interaction
[1]. Members of this family influence tissue specific differentiation
as demonstrated for Prdm1 in lymphoid cell maturation [2], and
Prdm16 in brown fat development [3]. Moreover, several
members of the family are deregulated in pathological settings,
most notably cancer, by acting either as oncogenes or tumor
suppressors [1].
PRDM5 localizes to human chromosome 4q26 and encodes,
aside from the PR domain, 16 C2H2 zinc fingers. PRDM5 has
previously been reported to lack intrinsic histone methyltransferase
activity but to predominantly repress transcription by recruiting
G9a and HDACs enzymes to target genes [4]. Furthermore,
PRDM5 has been indicated as a potential tumor suppressor in
various cancers [5–7], but its role in mammalian development and
normal physiology has not been addressed. In zebrafish, Prdm5 loss
induces morphogenic defects due to impairment of convergent
extension movements at the gastrulation stage, likely resulting
from deregulation of the WNT inhibitor Dkk1 [8]. Recently,
mutations in PRDM5 were detected in Brittle Cornea Syndrome
(BCS) [9], a connective tissues disease characterized by thinning of
the cornea and a wide spectrum of additional symptoms including
dermal and skeletal defects [10].
Bone is composed of a highly specialized, mineralized collag-
enous matrix that provides tensile strength to the skeletal system.
Collagen I is the major component of osteoblasts matrix,
composed of a heterotypic triple helix derived from Col1a1 and
Col1a2 chains typically in a 2:1 stoichiometric ratio [11,12].
Approximately 40 collagen genes are annotated in mammalian
genomes encoding around 28 proteins and, of these, type I
collagen is part of the subfamily of fibrillar collagens [13].
Collagen chains are synthesized and assembled as triple helical
procollagen molecules. Extracellular proteinase cleavage of N- and
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C-terminal telopeptides leads to mature tropocollagen that is
further assembled into fibrils and fibers [14]. The latter process is
regulated by other extracellular macromolecules including pro-
teoglycans from the Small Leucine Repeat family (SLRP), such as
Decorin and Fibromodulin [15,16].
A number of transcription factors have been discovered as
regulators of collagen I genes (reviewed in [17,18]), such as Sp1
[19], Cebpb [20] or members of the AP1 family [21]. Furthermore,
a number of transcription factors are known to be key regulators of
bone development, such as Runx2 [22], which controls the
expression of a multitude of extracellular matrix (ECM) genes
essential for both the chondrogenic and osteogenic programs [23].
We present here a novel molecular function for Prdm5 in
sustaining transcription of key ECM genes. Prdm5 is highly
expressed in the osteoblast region of developing bones in vivo and
genome wide mapping of Prdm5 occupancy in osteoblastic cells
identifies all collagens and a number of SLRP genes as direct
targets for Prdm5. Interestingly, Prdm5 binds predominantly
within the exonic regions of collagen genes and its presence
dictates the amount of intragenic RNA polymerase II. Indeed,
Prdm5 sustains transcription of Collagen I genes by maintaining
RNA polymerase II occupancy throughout the Col1a1 gene, while
the binding to a distal enhancer element upstream of Decorin gene
suggests a further role in chromatin organization. Osteoblasts
lacking Prdm5 display decreased Collagen I and Decorin
expression leading to reduced Collagen I fiber assembly in vivo.
Downregulation of these key extracellular matrix genes likely
participates in the delayed ossification and decreased bone mineral
density observed in Prdm5 mutant mice. Our data defines novel
roles for Prdm5 as a transcriptional modulator of collagen genes
by influencing RNA polymerase II occupancy, as well by binding
to enhancer-like elements in osteoblastic cells.
Results
Prdm5 is expressed in developing bones of mouse
embryos
To address a possible role in mammalian development for
Prdm5, a gene-trap mouse model featuring the integration of a b-
galactosidase-neomycin (b-geo) cassette in intron 2 of the Prdm5
gene was generated (Prdm5LacZ). This cassette is preceded by a
splice acceptor site to direct exon 2-b-geo splicing and ends with a
poly-A site to terminate transcription (Figure 1A). In mutant cells,
expression of the Prdm5 locus results in the production of a fusion
transcript between the first two exons of Prdm5 (<60 amino acids)
and the b-geo cassette with a resulting fusion protein of
approximately 135 kDa in size (Figure S1A). To validate the
effectiveness of the gene-trap system, we quantified the levels of the
wt Prdm5 allele in Prdm5LacZ/LacZ embryonic fibroblasts and found
it to reach a maximum of 10% relative to the expression in wt
littermates (Figure S1A). In adult organs, except for brain, testis
and lung, we observed Prdm5 levels reduction to be at least 85%
in the tissues tested (Figure S1B). In contrast to the essential role in
zebrafish [8], Prdm5LacZ/LacZ mice are viable and fertile and the
mutant allele segregates according to Mendelian ratios (Figure
S1C). Gross pathology analysis did not reveal obvious abnormal-
ities and no notable differences in weight were detected between
mutant mice and wild type littermates up to the age of 56 weeks
(Figure S1D).
To characterize the expression pattern of Prdm5, we tracked the
b-galactosidase expression driven by the endogenous Prdm5
promoter by whole mount X-gal staining at various developmental
stages. At E10.5–12.5 the LacZ reporter was expressed in a diffuse
staining pattern along meso-endodermal derived regions with
higher intensity in the heart (Figure 1B and 1C). At E14.5 LacZ
staining accumulated in limbs and snout regions and in particular
in cartilaginous templates (Figure 1D). From E16.5 a specific
staining pattern was observed in skeletal elements, particularly in
long bones and ribs (Figure 1E). In these tissues LacZ was highly
expressed in the osteoblastic regions including the trabecular
compartment and periosteum/perichondrium (arrows in
Figure 1F). LacZ staining on sections from E16.5 embryo tibia
revealed that the Prdm5 promoter is active in a subpopulation of
cells in the osteoblast region (periosteum and trabecular area)
(Figure 1G), whereas no signal was detected in the hypertrophic or
proliferative chondrocytes zones (Figure 1G). Moreover, LacZ
staining of calvariae of Prdm5LacZ/LacZ mice at P0 indicated that
Prdm5 expression in osteoblasts is not restricted to long bones but
can be detected also in skull sutures and weakly in calvariae
(Figure 1H). Robust PRDM5 expression in osteoblasts was further
confirmed in primary human osteoblast cells isolated from healthy
donors, compared to a panel of human immortalized cell lines of
different origins (Figure S1E). Moreover we found comparable
Prdm5 expression levels in mouse primary calvarial osteoblasts,
the osteoblastic MC3T3 cell line and primary embryonic
fibroblasts (Figure S1F). In summary, in vivo expression analyses
confirmed Prdm5 as consistently expressed in osteoblastic com-
partments in the mouse.
Acute Prdm5 deregulation affects osteogenic
differentiation in vitro
Since Prdm5 is highly expressed in osteoblastic cells, we chose
the MC3T3 cell line model to investigate the roles of Prdm5 during
osteogenic differentiation. Cells were transduced with lentiviral
shRNA constructs against Prdm5, which resulted in efficient
reduction of both Prdm5 transcript and protein levels (Figure 2A).
Prdm5 depletion did not significantly affect proliferation of MC3T3
cells as assessed by BrdU labeling (data not shown) but led to a
significant reduction in matrix mineralization as measured by
Alizarin red staining of calcium nodules upon induction of
osteogenic differentiation (Figure 2B). In line with this, overex-
pression of PRDM5 induced the opposite phenotype resulting in
increased nodule formation (Figure 2C and 2D). In parallel, the
Author Summary
Bone provides the essential tensile strength of the skeletal
system, constitutes an important storage for minerals, and
hosts the initial differentiation stages of the hematopoietic
system. In addition, bones are important endocrine organs
affecting organismal metabolism. Consequently, many
human diseases arise from defects in bone formation or
homeostasis. Hence, deciphering the molecular mecha-
nisms underlying bone formation is essential for under-
standing the basis of bone and extracellular matrix-
associated diseases. Here, we provide a detailed charac-
terization of the cellular and molecular functions of the
transcription factor Prdm5 during murine bone formation
in vivo and find that Prdm5 is expressed in skeletal
structures during development and that its loss impacts
the ossification process, leading to a decrease in bone
mineral density. A genome-wide mapping of Prdm5
binding sites in pre-osteoblastic cells reveals an unprece-
dented role for a transcription factor in targeting virtually
all members of the Collagen and SLRP gene families.
Interestingly, Prdm5 predominantly binds exonic regions
of collagen genes and associates with RNA Polymerase II to
sustain Collagen I transcription.
Prdm5 Promotes the Transcription of ECM Genes
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significance of Prdm5 in chondrogenesis was evaluated by
knocking down Prdm5 in the ATDC5 chondrogenic cell line
(Figure S2A). In this system, Prdm5 loss did not affect
chondrogenic differentiation, as evaluated by measuring glycos-
aminoglycan deposition (Figure S2B).
To investigate transcriptional changes imposed by Prdm5 loss in
primary osteoblasts, expression levels of a series of osteogenic
markers in Prdm5 wild type and mutant calvarial osteoblasts were
measured by qRT-PCR. Significant reduction was observed for
transcripts encoding Osteocalcin (Bglap1) and Bone sialoprotein
(Ibsp), both late osteoblast markers, while transcript levels for early
markers such as Osteopontin (Spp1), Osterix (Sp7) and Runx2 were
unchanged (Figure 2E). When assayed for mineralization activity,
no difference in matrix calcification was detected by Alizarin red
staining in calvarial osteoblasts from cohorts of WT and mutant
animals (Figure S2C and S2D). However, this phenotype may
depend on cellular adaptation in culture, since treatment of wild
type calvarial osteoblasts with a siRNA oligo which efficiently
reduces Prdm5 levels, resulted in decreased matrix mineralization
after 14 days of osteogenic stimulation (Figure S2E).
Collectively, the data indicate that Prdm5 exerts a cell-
autonomous function in the osteogenic pathway.
Prdm5 targets gene bodies of transcriptionally active
genes via a consensus sequence
To unveil the molecular functions of Prdm5 in osteoblastic cells
and identify direct target genes, chromatin immunoprecipitation
followed by deep sequencing (ChIP-seq) was performed for Prdm5
in the MC3T3 cell line.
Two different Prdm5 polyclonal antibodies were generated and
western blot analysis of Prdm5 wild type and mutant mouse
embryonic fibroblasts revealed that these antibodies recognize
distinct epitopes (Figure S3A), and both were confirmed as suitable
for ChIP experiments (Figure S3B).
Data from ChIP-seq analyses with the two antibodies were
overlaid resulting in 1712 common loci we defined as high
confidence Prdm5 target regions (Figure S3C and Table S1).
Interestingly, 29% of Prdm5 peaks resided in promoter regions,
while 39% of the peaks resided inside the body of genes
(Figure 3A). Across all genes, Prdm5 binding was distributed
throughout the length of target genes with the highest density
around the TSSs (Figure 3B). A de novo motif finding algorithm for
Prdm5 peak centers identified a putative consensus sequence for
Prdm5 binding (Figure 3C). This sequence bears strong similarity
to a Prdm5 consensus previously identified by in vitro random
Figure 1. Prdm5 is expressed in osteoblast regions of developing bones. A) Scheme for the generation of the Prdm5LacZ/LacZ mouse strain.
B–E) X-gal stainings of Prdm5LacZ/LacZ embryos at E10.5 (B), E12.5 (C) E14.5 (D) and E16.5 (E). F) E16.5 embryo image detail. LacZ reporter expression in
the perichondrium and growth plate of femur and ribs is marked by arrows. G) X-gal staining of tibiae section from E16.5 Prdm5 mutant embryo.
Juxtaposition of three pictures (separated by white lines) to represent the whole length of a tibia. Indicated are different compartments:
PC = proliferative chondrocytes, HC =hypertrophic chondrocytes, OB=osteoblasts. Periosteum is marked by asterisks. H) Whole mount X-gal staining
of Prdm5LacZ/LacZ newborn skull at P0. Pronounced staining in sutures is indicated with an arrow. Bars = 1 mm, except for (G) where bar = 200 mm.
doi:10.1371/journal.pgen.1002711.g001
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Figure 2. Prdm5 deregulation impairs osteogenic differentiation in vitro. A) Upper panel. qRT-PCR of Prdm5 levels in MC3T3 cells transduced
with lentiviral shRNA constructs against Prdm5 (shPrdm5-a and shPrdm5-b) and control construct. Lower panel. Prdm5 western blot from the same
experiment. Tubulin is included as loading control. B) Upper panel. Quantification of Alizarin red staining after 21 days of osteogenic differentiation in
MC3T3 cells. Data are presented as mean of 3 independent experiments 6 SEM. ** = p,0.01 and *** = p,0.005 (t-test). Lower panel. Representative
image from osteogenic differentiation experiments. C) Western blot showing overexpression of human PRDM5 (marked with star) in MC3T3 cells
(filled circle = endogenous Prdm5). GFP overexpression is used as a negative control and Vinculin western blot for equal protein loading. D)
Quantification of Alizarin red staining from osteogenic differentiation experiments of MC3T3 cells overexpressing GFP or PRDM5. A representative
experiment is shown and data are presented as average 6 standard deviation. E) qRT-PCR analysis of WT and Prdm5LacZ/LacZ calvaria osteoblasts for
Prdm5 Promotes the Transcription of ECM Genes
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oligonucleotide selection experiments (Figure S3D) [4]. To
confirm whether DNA fragments containing the identified
sequence motif were directly recognized by Prdm5, in vitro
pulldown assays using biotinylated DNA oligonucleotide probes
were performed. Overexpressed HA-PRDM5 readily bound to
DNA probes containing the consensus motif (a region of Col1a1
exon 33, containing 3 motifs with p-score 0.96), whereas the
binding was impaired by mutation of the first and last two
guanines of the consensus motifs (Figure 3C).
Gene activity in MC3T3 cells was also estimated by performing
ChIP-seq on the same chromatin preparation for total RNA
polymerase II, histone H3 lysine 4 trimethylation (H3K4me3) and
H3 lysine 9 trimethylation (H3K9me3), allowing for a correlation
of Prdm5 binding to gene activity. Prdm5 bound genes were
enriched either for the presence of H3K9me3 or H3K4me3, with
a strong preference for Prdm5 target genes to present H3K4me3
peaks around their TSS, when compared to the average of 100
permutations of a size-matched set of random genes (Figure 3D).
These results indicate that Prdm5 may act both as a transcriptional
repressor and activator in a promoter-dependent fashion and that
in MC3T3 cells the majority of Prdm5 target genes are actively
transcribed. Indeed, Prdm5 target genes were also associated with
RNA polymerase II occupancy (to a similar extent as H3K4me3)
(Figure 3D) and expression analysis from microarray data of
MC3T3 cells showed that genes bound by Prdm5 are character-
ized by a general increase in expression signal with respect to the
total of the genes represented on the microarray (Figure 3E).
Prdm5 targets genomic loci encoding collagen genes
and sustains collagen I transcription in osteoblasts
Annotation of the Prdm5 bound loci and detailed analysis
followed by ChIP-qPCR validation on independent samples with
both Prdm5 antibodies strikingly revealed that 42 of 43 collagen
genes in the mouse genome contained at least one Prdm5 peak
(Figure 4A). Moreover, the results were validated in primary wt
and LacZ/LacZ calvarial osteoblasts, where Prdm5 enrichment
was strongly reduced in mutant cells (Figure S4A and S4B).
When genomic regions bound by Prdm5 were subsequently
annotated according to biological processes, a strong enrichment
was observed for genes associated with collagen fibril and
extracellular matrix organization, as well as bone development
(Figure 4B). Prdm5 binding to collagen genes occurred almost
osteogenic markers as indicated. Expression values were normalized to a panel of housekeeping genes (Rps18, Ubc, Actb, Rpl0) and indexed to the
average expression value of wild type clones. * = p,0.05 and *** = p,0.001, by unpaired T-test, +/+ (n = 14), LacZ/LacZ (n = 19).
doi:10.1371/journal.pgen.1002711.g002
Figure 3. Analyses of Prdm5 chromatin interactions. A) Diagram illustrating the overall distribution of Prdm5 binding sites categorized
according to the distance from the nearest TSS (see Text S1). B) The mean distribution of tags across gene bodies for Prdm5 ChIP-seq (Prdm5-ab1 in
blue, Prdm5-ab2 in red and IgG in black). Vertical dashed line at x = 0 represents the TSS. Positions after the TSS are represented as % of the length of
the gene. C) Upper panel. Slogos plot produced using the motifs detected by the Weeder program from Prdm5 ‘‘shrunk’’ peaks (see Text S1). Lower
panel. DNA pulldown assay from nuclear extract of 293 cells overexpressing HA-PRDM5 using biotinylated oligos representing the Col1a1 exon 33
(WT) and a mutated control sequence (G-A/T Mut). D) Histogram showing the percentage of H3K9me3 (left panel), H3K4me3 (middle panel) and RNA
Polymerase II (right panel) positivity for ‘‘Random sampling’’ (mean value of 100 iterations for 1446 random genes sets) or for Prdm5 target genes. (E)
Q-Q plot comparing the quantile distribution of Prdm5 target genes’ expression (on Y axis) and all genes (on X axis). Red line is reference line
representing equal quantile distribution.
doi:10.1371/journal.pgen.1002711.g003
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Figure 4. Prdm5 targets all collagen genes and regulates type I collagen expression. A) ChIP-qPCR validation of Prdm5 peaks in collagen
genes or negative control regions from an independent chromatin preparation immunoprecipitated with IgG, Prdm5-Ab1 (in black and blue
respectively, plotted on left Y axis) or Prdm5-Ab2 (in red, plotted on right Y axis). Orange horizontal line represents the highest ‘‘noise’’ value obtained
by ChIP-qPCR on a set of negative regions. B) Biological processes enrichment from gene ontology annotation of Prdm5 target regions. C)
Distribution of the ‘‘peak centre’’ position for collagen genes targeted by Prdm5 or random sampling of Prdm5 target genes according to genetic
feature. D) Correlation between Prdm5-Ab1 coverage inside the gene body of all mouse collagen genes (X-axis) and Pol II coverage in the same
regions (Y-axis) normalized by base pairs. E) qRT-PCR for Prdm5, Col1a1 and Col1a2 in MC3T3 cells treated for 72 hours with siRNA oligos against
Prdm5 (siPrdm5-1 and -2) or controls. Results are presented as average of four independent experiments 6 SD; * = p,0.05, ** = p,0.01. F) Upper
panel. ChIP-qPCR for RNA Pol II in WT and mutant (blue and red respectively) calvarial osteoblasts along the Col1a1 gene. IgG control is represented
by black and green lines respectively. X-axis = distance (in bp) from Col1a1 TSS, * = p,0.05 (unpaired t-test). Lower panel. Genome browser snapshot
of the corresponding Col1a1 genomic region displaying MC3T3 tracks for: qPCR amplicons, IgG, RNA Pol II and Prdm5-Ab1 coverage. G) Western blot
from co-immunoprecipitation experiment of HA-PRDM5 in HEK293 cells; endogenous interacting proteins or IgG are indicated.
doi:10.1371/journal.pgen.1002711.g004
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exclusively in the gene body with approx. 60% of peaks centered
in exonic regions (Figure 4C). Importantly, Prdm5 occupancy in
the body of collagen genes correlated with the amount of bound
RNA polymerase II in the same regions (Figure 4D), suggesting a
role for Prdm5 in sustaining transcriptional activity of the collagen
gene family.
Very high enrichment for Prdm5 binding was observed in the
two genomic loci corresponding to the collagen I genes Col1a1 and
Col1a2 (Figure 4D and Figure S4C). Prdm5 knockdown by means
of two siRNA oligos demonstrated that Prdm5 occupancy in
Col1a1 and Col1a2 genes was functionally relevant, as reduction in
Prdm5 levels led to a decrease in transcript and protein levels of
both type I collagen genes (Figure 4E and Figure S4D). This effect
was observed also in primary osteoblasts upon genetic ablation of
Prdm5 (Figure S4E). Given the close correlation between Prdm5
occupancy and RNA polymerase II presence, we measured the
occupancy of the latter along the whole length of the Col1a1 gene
in Prdm5 wild type and mutant osteoblasts. While RNA
polymerase II levels were unchanged in LacZ/LacZ cells at the
Col1a1 TSS, we observed a significant drop in RNA polymerase II
levels in mutant Prdm5 osteoblasts between +6.2 kb and the end of
the Col1a1 gene (Figure 4F). Towards understanding the mech-
anism, we hypothesized that Prdm5 could affect RNA polymerase
II by direct interaction. Indeed, overexpressed HA-PRDM5 co-
immunoprecipitated with endogenous RNA polymerase II and
with higher affinity to the elongating form of RNA polymerase II
as evident from analysis using a phospho-serine 2 specific RNA
polymerase II antibody (Figure 4G). In summary, Prdm5 targets
virtually all the collagen genes in the mouse genome and high
Prdm5 occupancy inside the Col1a1 gene body promotes RNA
polymerase II occupancy and transcription.
Prdm5 regulates Decorin via a distal element with an
enhancer-like chromatin signature
Analyses of the annotation of Prdm5 bound loci revealed that
the Prdm5 target repertoire extends to genomic regions encoding
other ECM genes involved in collagen fibrillogenesis, such as
Periostin (Postn) and genes from the SLRP family, such as Decorin
(Dcn), Fibromodulin (Fmod), Biglycan (Bgn) and Epiphycan (Epc).
Also in this case, Prdm5 occupancy on selected targets was
validated in independent samples from MC3T3 cells (Figure 5A),
as well as primary calvarial osteoblasts (Figure S5A and S5B).
Since Decorin is well known to regulate collagen fibrillogenesis,
we analyzed the influence of Prdm5 on Decorin expression.
Indeed, we observed that Prdm5 knockdown resulted in decreased
Decorin transcription (Figure 5B). This effect could be reproduced
in Prdm5LacZ/LacZ calvarial osteoblasts (Figure 5C). While cell-
associated Decorin protein levels were only mildly decreased upon
Prdm5 knockdown (Figure 5D), the amount of secreted Decorin
detected in cell culture media from Prdm5 siRNA treated cells was
strongly reduced (Figure 5D). A closer inspection revealed that the
Prdm5 binding site assigned to Decorin gene was 100 kilobases
distant from its TSS, suggesting the binding to a distal enhancer
(Figure S5C). Chromatin immunoprecipitation for H3K4me1 and
H3K27ac confirmed that Prdm5 bound a site upstream of Dcn
with a chromatin signature corresponding to an enhancer element
(Figure 5E). Our data show that Prdm5 targets SLRP family
members and likely regulates Decorin via a distal enhancer.
Delayed ossification and impairment of collagen
fibrillogenesis in Prdm5LacZ/LacZ embryos
Collagen I is the main component of osteoblastic ECM [11] and
Decorin is known to regulate collagen I fibrillogenesis [16]. The
observed Prdm5 regulation of Collagen I and Decorin genes
prompted us to characterize their deregulation in vivo and the
resulting phenotype in Prdm5LacZ/LacZ mice. qRT-PCR analyses
revealed that the Col1a1 and Col1a2 transcripts were significantly
reduced upon Prdm5 loss in E16.5 limbs (Figure S6A). Moreover,
decreased Collagen I was observed by in situ hybridization in the
periosteum at E16.5 (data not shown), as well as by immunoflu-
orescence microscopy (Figure 6A). While Decorin transcript levels
were unchanged in whole E16.5 mutant limbs (Figure S6B),
immunofluorescence staining displayed reduction of Decorin
protein, particularly in the periosteum and invading osteoblasts
region (Figure 6A), indicating an osteoblast-restricted Prdm5
regulation of Decorin. Given that both molecules are involved in
collagen fiber formation, fibrillar collagen levels were evaluated in
Prdm5LacZ/LacZ embryonic limbs by picrosirius red staining. Using
bright field microscopy, a decreased staining of collagen could be
appreciated in the mutants (Figure S6C). Moreover, using
polarized light to visualize specifically assembled collagen fiber
birefringency, a marked decrease in the presence and organization
of collagen fibers was observed in Prdm5LacZ/LacZ embryonic limbs
(Figure 6A).
Histological examination revealed a shorter osteoblast com-
partment in mutant animals (Figure 6B), suggesting a delay in the
ossification process. Likewise, Von Kossa stainings revealed
decreased calcification in mutant limbs further pointing to an
impaired ossification process in Prdm5 mutants (Figure 6C). To
quantitate the delayed ossification, wild type and Prdm5LacZ/LacZ
E18.5 embryos were analyzed by micro-CT (mCT) scanning.
Quantification of total bone volume demonstrated a significant
reduction in the ossification process in mutant embryos
(Figure 6D). However, at E16.5, no overt differences in the
expression of various bone formation markers were observed
(Figure S6D). To measure the impact of the embryonic ossification
defect in young mice hind limbs from cohorts of WT and
Prdm5LacZ/LacZ mice of both genders were analyzed by peripheral
Quantitative Computed Tomography (pQCT). Images of distal
metaphyseal sections from CT-scans of femurs at 5 weeks of age
demonstrated a decrease in bone mineral density (Figure 6E).
Quantification of total bone mineral density, total mineral content
and total bone area in large cohorts of mice demonstrated a
statistically significant reduction in all three parameters in
Prdm5LacZ/LacZ mice of both genders (Figure 6F and Table S2).
Separate measurements of the cortical and trabecular compart-
ments revealed a more robust reduction in all measured
parameters in cortical regions than trabecular areas (Table S2),
coinciding with the areas where downregulation of Collagen I and
Decorin was predominantly observed in mutant embryo limbs.
In summary, Prdm5LacZ/LacZ animals display a significant
reduction in collagen levels and fibrillogenesis, likely resulting in
the observed osteopenic phenotype.
Discussion
In this study, we uncover a novel function for Prdm5 in
promoting the transcription of key extracellular matrix genes in
osteoblastic cells. We find that Prdm5 is specifically expressed in
the osteoblastic compartment of developing bones and exerts its
function along the osteogenic lineage by promoting osteogenic
differentiation in culture. Mechanistically, we demonstrate that
Prdm5 targets ECM gene families such as collagens and small
leucine-rich proteoglycans. By association with RNA polymerase
II, Prdm5 sustains the transcription of collagen I genes, while the
regulation of Decorin expression is mediated via binding to a distal
enhancer-like element. Prdm5 regulation of these genes occurs in
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Figure 5. Prdm5 regulates Decorin through a distal enhancer. A) ChIP-qPCR validation of Prdm5 peaks on selected ECM genes or negative
regions from an independent sample immunoprecipitated with IgG, Prdm5-Ab1 (in black and blue respectively, plotted on left Y axis) or Prdm5-Ab2
(in red, plotted on right Y axis). Orange horizontal line represents the highest ‘‘noise’’ value obtained by ChIP-qPCR on a set of negative regions. B)
qRT-PCR analysis of Decorin transcript (Dcn) levels upon Prdm5 knockdown as in Figure 4E. Results are presented as average of four independent
experiments +/2 SD; * = p,0.05. (C) qPCR analysis of WT and Prdm5LacZ/LacZ calvarial osteoblasts for Decorin. Expression values were normalized to
the control WT samples. * = p,0.05; T-test, (+/+ n= 14, LacZ/LacZ n= 19 clones). D) Upper panels. Western blot analysis of Decorin levels upon Prdm5
knockdown in cell layers; Tubulin is used as loading control. Lower panels. Western blot analyses of purified proteoglycans from cell culture media
from knockdown cells. Tubulin is used as purity control and Fibronectin for equal protein loading. E) ChIP-qPCR with indicated antibodies for Prdm5
binding site upstream of Dcn gene. Meg3 TSS region is used as negative control.
doi:10.1371/journal.pgen.1002711.g005
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vivo in developing limbs resulting in the decreased bone mineral
density observed in Prdm5LacZ/LacZ animals.
Members of the PRDM family display tissue specific patterns of
expression [24], in agreement with a role in tissue specific
differentiation. In line with this, Prdm1 is known to be a master
regulator of lymphoid differentiation [2], Prdm16 to control
brown fat development [3], Prdm14 to regulate embryonic stem
cell pluripotency and germ cell differentiation [25,26] and Prdm9
to determine meiotic recombination hotspots [27]. So far Prdm5
has not been characterized in the context of mammalian
development. Our study thus provides the first evidence of a role
for Prdm5 in tissue specific differentiation extending the concept of
PRDM proteins as regulators of specific tissues and in agreement
with the idea of functional specialization of PRDM members
during expansion of the family in vertebrates [28].
The identification of high Prdm5 expression in osteoblasts and
its function in osteogenic differentiation in vitro permitted us to
evaluate its molecular functions in a relevant cellular context.
Indeed, it is noteworthy that Prdm5 silencing does not restrict
chondrogenic differentiation in vitro suggesting cell type specificity
in Prdm5 action.
By genome wide mapping of Prdm5 binding sites in a pre-
osteoblastic cell line, we demonstrate a unique capacity of Prdm5
to bind the whole family of collagen genes and especially to bind
these genes within the gene body. This is an unprecedented feature
for a transcriptional regulator, i.e. binding the gene bodies of all
the members of such a large gene family. Moreover, we observed
Prdm5 occupancy in genomic regions encoding for non-collagen
proteins with collagenous domains (e.g. C1q family), suggesting
that either Prdm5 consensus sequence is overrepresented in
genomic regions encoding for collagenous domains, or that simply
Prdm5 binds common regulatory elements shared by specific gene
families. Indeed we detected Prdm5 binding to several members of
the SLRP family as well as a number of genes encoding for
essential extracellular matrix components (complete list in Table
S1), demonstrating that Prdm5 potentially regulates a wide but
specific transcriptional program necessary for proper extracellular
matrix formation.
In this study, we focus on fibrillar collagens, particularly
Collagen I genes; these were highly enriched for Prdm5 binding
and are essential constituent of osteoblastic matrix. A number of
transcription factors have been shown to regulate Collagen I genes
and the location of their binding sites on Col1a1 and Col1a2
promoters have been shown to determine the expression in
different osteoblast subtypes [29,30]. Very little is known
concerning the regulation of Col1a1 and Col1a2 gene expression
by factors binding downstream of their promoter, except for a
repressor region located within intron 1 that can recruit GATA
and IRF proteins to block enhancer stimulation of promoter
activity [31,32]. To our knowledge, Prdm5 is the first example of a
transcriptional modulator able to bind a consensus sequence found
inside collagen genes, particularly Col1a1 and Col1a2.
Interestingly, upon Prdm5 loss in osteoblasts, we observe
decreased RNA polymerase II occupancy throughout the gene
body of the Col1a1 gene, while at the TSS, RNA polymerase II
occupancy remains unchanged. This suggests that Prdm5 is
sustaining transcription of the Col1a1 gene by affecting polymerase
processivity. This hypothesis is further supported by the observed
interaction between Prdm5 and RNA polymerase II. The higher
enrichment for the processive, ‘‘elongating’’, form of RNA
polymerase II phosphorylated on Serine 2 of its C-terminal
domain, argues in favor of Prdm5 directly sustaining RNA
polymerase II processivity although further analyses are required
to clearly define the underlying mechanism. Since Prdm5 binds
predominantly exonic regions of collagen genes, and splicing is
known to occur co-transcriptionally [33], there may be a role for
Prdm5 in the coupling of splicing to transcription. However, we
failed to detect an altered Col1a1 splice pattern in Prdm5 mutant
osteoblasts (data not shown), making this hypothesis less likely. The
correlation between Prdm5 binding levels within collagen genes
and RNA polymerase II occupancy suggests that Prdm5 in certain
contexts may act as a transcriptional activator in contrast to the
previously described role of PRDM5 acting predominantly as a
transcriptional repressor [4]. Interestingly, we observe major
enrichment for Prdm5 target genes to be transcriptionally active,
presenting both H3K4me3 and RNA Polymerase II (Figure 3D),
suggesting a predominant role for Prdm5 in transcriptional
activation in osteoblastic cells.
The Prdm5 target repertoire extends also to SLRP genes,
including Decorin (Dcn), Fibromodulin (Fmod), Biglycan (Bgn) and
Epiphycan (Epc). Members of this family are involved in correct
type I collagen fibers assembly [15]. Specifically, we found a
Prdm5 binding site residing 100 kb upstream from the Dcn TSS.
Decorin is the closest gene within a range of 760 kb and the Prdm5
binding site displays the chromatin signature of an enhancer
element, suggesting a previously undiscovered role for Prdm5 in
transcriptional enhancement or chromatin organization. Decorin
has been shown to bind directly collagen I [34] and, in bone
tissues, mice lacking Decorin display decreased collagen fiber
diameter, although they do not show pronounced skeletal defects
[35]. Our data show a marked decrease in fibrillar collagen
staining, as evaluated by collagen fibers birefringency, indicating
that downregulation of both Collagen I transcripts as well as
Decorin might contribute to the skeletal phenotype observed.
Of direct relevance, mutations in PRDM5 were recently
detected in Brittle Cornea Syndrome [9]. Brittle Cornea
Syndrome is a generalized connective tissue disease characterized
by impairment of ECM formation and patients develop a number
of other symptoms, aside from ocular defects, such as skin
hyperelasticity, joint hypermobility and skeletal defects [10,36].
While no studies so far have causally linked PRDM5 to this
disease, our data demonstrating that Prdm5 regulates the
expression of fibrillar collagens are in line with the defects in
ECM production and assembly characteristically observed in BCS
patients. The distinct expression pattern observed for Prdm5 in
developing skeleton prompted us to evaluate a bone phenotype but
future studies will be needed to understand if Prdm5LacZ/LacZ mice
develop also corneal, skin and joint defects resembling BCS or
Figure 6. Prdm5 loss results in decreased Collagen I and Decorin levels and leads to reduced bone formation in vivo. A)
Immunofluorescence staining of E16.5 tibiae for Collagen I (upper panel, bar = 200 mm), Decorin (middle panel, bar = 100 mm, asterisk indicates
periosteum area) and Picrosirius red staining of WT and Prdm5LacZ/LacZ E16.5 tibiae under polarized light (lower panel, bar = 100 mm). B) H&E staining
of Prdm5 WT and Prdm5LacZ/LacZ E16.5 bones. The bars indicate the length of the osteoblast region (bar = 100 mm). C) Von Kossa staining of WT and
Prdm5LacZ/LacZ E16.5 tibiae. D) mCT measurements of E18.5 embryos. BV/TV=Bone volume/Total embryo volume. Values for Prdm5LacZ/LacZ embryos
are normalized to littermate controls. * = p,0.05; T-test with Welch correction. E) Representative pictures from pQCT scans of femoral metaphysis of a
5 weeks old Prdm5LacZ/LacZ mouse and a littermate control. Color bar represents the density scale. F) Quantification of total bone mineral density in
femoral metaphysis from 5 weeks old WT and Prdm5LacZ/LacZ animals. Each dot represents the average of two measurements on each animal tested
(n = 9/10 per group).
doi:10.1371/journal.pgen.1002711.g006
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related diseases such as Ehlers-Danlos syndrome. In this regard,
considering the capability of Prdm5 to bind genomic loci encoding
multiple collagen molecules, it may be that Prdm5 affects the levels
of specific collagen molecules in a context-specific fashion. These
features support the role for Prdm5 as an important regulator of
extracellular matrix genes transcription during the process of bone
formation, and extend the need for studies characterizing this
protein in different clinical settings.
Materials and Methods
Animal experiments
To generate the Prdm5LacZ strain, ES cell clone AV0702 from
the Sanger Institute Gene Trap project was microinjected into
C57BL/6 blastocysts. The integration site of the b-geo cassette
was established using long range PCR with primers spanning
different regions of intron 2 and a genotyping strategy was devised
accordingly. All experiments were performed on mice backcrossed
for at least 6 generations into the C57BL/6 strain and
comparisons between WT and mutant animals always refer to
littermates. All animal experimentation was performed with
approval from Danish authorities (Dyreforsøgstilsynet, protocol
number 2006/562-43) and the Regierung von Oberbayern
(Government of Upper Bavaria).
Histological staining and immunohistochemistry
For whole mount X-gal staining, embryos were deskinned (after
E15) and fixed in 0.25% glutaraldehyde (Sigma). Stainings were
performed by incubation in staining solution containing 0.02%
NP40, 0.01% Sodium Deoxycholic acid, 2 mM MgCl2, 20 mM
Tris-HCl (pH 7.4), 50 mM K-Ferrocyanide, 50 mM K-Ferricya-
nide, 1 mg/mL X-gal in PBS (chemicals purchased from Sigma).
Stained embryos were post-fixed in 4% paraformaldehyde and
cleared in increasing concentrations of glycerol in 1% KOH.
Images were acquired with a Leica D-Lux 3 on Leica S6D
stereoscope. Von Kossa staining was performed by staining
dehydrated sections in 1% AgNO3 under UV light, followed by
incubation with 5% Sodium thiosulfate. Picrosirius red stainings
were performed as described [37]. Images were acquired under
polarized light using a BX51 Olympus microscope. In-situ
hybridization was performed as previously described [38] and
protocols for immunofluorescence stainings are described in Text
S1.
Cell culture and transfections
Primary human osteoblasts (kindly provided by Bente Langdahl,
A˚rhus University, Denmark) were isolated from bone biopsies of
healthy donors. MC3T3 cells were maintained in Alpha-MEM
(Gibco) with 10% FBS (Hyclone) and 1% penicillin-streptomycin
(Gibco). ATDC5 cells were maintained in DMEM:F12 (Gibco)
media supplemented with 5% FBS, 10 mg/ml human transferrin
(Roche) and 30 nM sodium selenite (Sigma). Calvarial osteoblasts
were derived as previously described [21]. Differentiation proto-
cols and transfection/transduction techniques are detailed in Text
S1.
Co-immunoprecipitation, immunoblotting, and gene
expression analyses
For co-immunoprecipitation experiments HEK293 cells were
transfected with indicated plasmids and, 48 hours after, lysed in
ELB buffer (150 mM NaCl, 50 mM HEPES, 0.1% Igepal) and
incubated with HA-agarose beads (Sigma) overnight. After washes,
proteins were recovered by boiling beads in SDS Laemmli buffer.
For whole cells lysate immunoblotting, cells were harvested and
lysed in RIPA buffer and subjected to standard SDS-PAGE.
Protocols and antibodies used are detailed in Text S1.
Total RNA was extracted from cell pellets using the RNeasy
Plus Mini Kit (Qiagen) according to the manufacturer’s instruc-
tions. cDNA was synthetized using TaqMan Reverse Trancription
Reagents (Applied Biosystems). qRT-PCR was performed with the
One Step plus Sequence Detection System (Applied Biosystems)
using Fast SYBR green master mix reagent (Applied Biosystems).
Gene expression levels were normalized to the average of at least
two housekeeping genes. qPCR primers sequences are listed in
Table S3. For MC3T3 microarray data, RNA was amplified and
labeled using TotalPrep RNA Amplification Kit (Ambion) and
hybridized to MouseWG-6 v2.0 Expression BeadChip array
(Illumina) according to manufacturer’s recommendation.
Chromatin immunoprecipitation and Deep sequencing
Chromatin immunoprecipitation assay (ChIP) protocol and
antibodies used are detailed in Text S1. Libraries for sequencing
were obtained using the ChIP-seq DNA sample prep kit (Illumina)
according to manufacturer recommendations and samples were
sequenced on a Genome Analyzer II sequencer (Illumina). Primers
for ChIP-qPCR experiments are listed in Table S3.
Bioinformatic analysis
Microarray and ChIP-seq analyses are detailed in Text S1.
mCT and Peripheral quantitative computed tomography
E18.5 embryos were scanned using a micro CT scanner (model
1172, Skyscan, Belgium) at 50 kV, 200 mA and a 0.5 mm
aluminium filter. Adult mice at 5 weeks of age were analyzed by
pQCT using Stratec XCT Research SA+ (Stratec Medizintechnik
GmbH, Germany) at the German Mouse Clinic [39]. Analyses
details are provided in Text S1.
Supporting Information
Figure S1 Prdm5LacZ/LacZ mice do not display gross abnormalities
and PRDM5 is expressed in osteoblasts. A) Left panel. Western
blot of +/+ and LacZ/LacZ mouse embryo fibroblasts using
serum from mice immunized with recombinant Prdm51-142. Right
panel. qPCR for Prdm5 wt and Prdm5-bgeo fusion alleles in mouse
embryo fibroblasts of the three genotypes. B) qPCR for Prdm5 wild
type transcript in a panel of tissues from wild type and Prdm5LacZ/
LacZ mice. Results are shown as the average of 3 animals per group
6 standard deviations. C) Number of mice obtained at weaning
with different genotypes from Prdm5+/LacZ intercrosses. In
parenthesis the expected numbers according to Mendelian ratios.
Statistical differences were calculated by Chi-square test. D)
Weight of wild type and Prdm5LacZ/LacZ mice up to 56 weeks of age.
E) qPCR analysis for PRDM5 in primary human osteoblasts from
6 different donors (black bars) and a panel of human immortalized
cell lines of different origins (grey bars). F) Western blot analysis of
Prdm5 protein expression in the indicated mouse cell lines.
* = unspecific bands for equal loading.
(PDF)
Figure S2 Prdm5 knockdown affects osteogenic differentiation
in vitro, but not chondrogenic differentiation. A) Left panel. qPCR
of Prdm5 levels in chondrogenic ATDC5 cells infected with
lentiviral shRNA constructs against the Prdm5 transcript
(shPrdm5-a) and control construct. Right panel. Western blot
measuring Prdm5 protein levels in the same cells. Actin is used as a
control for equal protein loading. B) Upper panel. Quantification
Prdm5 Promotes the Transcription of ECM Genes
PLoS Genetics | www.plosgenetics.org 11 May 2012 | Volume 8 | Issue 5 | e1002711
of glycosaminoglycans deposition from ATDC5 cells infected with
control or shPrdm5-a constructs after 17 days of stimulation with
chondrogenic media and stained with Alcian blue. Data are
presented as the mean of 2 independent experiments 6 standard
deviation. Lower panel. Representative picture from the chon-
drogenic differentiation experiment. C) Representative pictures of
alizarin red stained WT and Prdm5LacZ/LacZ calvarial osteoblasts
after 14 days of osteogenic differentiation. D) Quantification of the
alizarin red staining from osteogenic differentiation experiments in
WT and Prdm5LacZ/LacZ calvarial osteoblasts. Data are presented as
mean 6 standard deviation for 10 different littermate primary
cultures per group. E) Left panel. Western blot measuring Prdm5
protein levels in primary calvarial osteoblasts treated for 72 hours
with control oligo or siRNA pool against Prdm5 (siPrdm5).
Vinculin is used as a control for equal protein loading. Right
panel. Quantification of calcified matrix deposition from calvarial
osteoblasts treated with control or siPrdm5 after 14 days of
stimulation with osteogenic media and stained with Alizarin red.
Data are presented as the mean of 4 independent experiments 6
standard deviation. Lower panel. Representative picture from the
osteogenic differentiation experiment.
(PDF)
Figure S3 Validation of Prdm5 ChIP-grade antibodies. A)
Western blot of +/+ and LacZ/LacZ mouse embryo fibroblasts
using Prdm5 rabbit polyclonal antibodies Prdm5-ab1 and Prdm5-
ab2. B) Left panel. Transfection control of HEK293 cells
containing a stably integrated GAL4TkLuc reporter with empty
vector or vector expressing Prdm5 fused to Gal4 DNA binding
domain (Gal4BD-Prdm5 OE). Tubulin is used for equal protein
loading. Right panel. Chromatin immunoprecipitation from
Gal4BD-Prdm5-OE sample with IgG (negative control), Gal4
(positive control) and a range of in house-generated or commer-
cially available Prdm5 antibodies. C) Venn diagram of the overlay
of peaks identified by ChIP-seq in MC3T3 in experiment either
with Prdm5-ab1 or Prdm5-ab2. D) Slogo representation of re-
analysis of sequences retrieved by previously published random
oligonucleotide experiment [4].
(PDF)
Figure S4 Prdm5 binds inside Col1a1 and Col1a2 gene bodies
and regulates their transcription. A) ChIP-qPCR in primary
calvarial osteoblasts with IgG or Prdm5-ab1 (black and red bars
respectively) for Prdm5 binding site in selected collagen genes.
Genomic regions around Meg3 and Sema5b are used as negative
controls. Orange horizontal line represents the highest ‘‘noise’’
value obtained by ChIP-qPCR on a set of negative regions. B)
ChIP-qPCR in wild type (red bars) and Prdm5LacZ/LacZ (blue bars)
calvarial osteoblasts for a number of collagen genes. Genomic
regions around Meg3 and Sema5b are used as negative controls.
Orange horizontal line represents the highest ‘‘noise’’ value
obtained by ChIP-qPCR on a set of negative regions. C) Genome
browser snapshot for Col1a1 (upper panel) and Col1a2 (lower panel)
regions. Tracks represent IgG, Prdm5-Ab1 and Prdm5-Ab2
sequencing results as indicated. D) Western blot for Prdm5 and
Collagen I levels from MC3T3 cells treated for 72 hours with
control or Prdm5 siRNA oligos. Tubulin is used for equal protein
loading. E) qPCR analysis of WT and Prdm5LacZ/LacZ calvarial
osteoblasts for Col1a1and Col1a2. Expression values were normal-
ized to WT controls. *** = p,0.001 according to T-test, (+/+
n = 14, LacZ/LacZ n = 19 clones).
(PDF)
Figure S5 Prdm5 binds a distal element from Dcn gene TSS in
calvarial osteoblasts. A) ChIP-qPCR in primary calvarial osteo-
blasts with IgG or Prdm5-ab1 (black and red bars respectively) for
Prdm5 binding site assigned to ECM genes identified from ChIP-
seq. Genomic region around AdamTS9 is used as negative control.
Orange horizontal line represents the highest ‘‘noise’’ value
obtained by ChIP-qPCR on a set of negative regions. B) ChIP-
qPCR in wild type (red bars) and Prdm5LacZ/LacZ (blue bars)
calvarial osteoblasts for the main peaks assigned to ECM genes
identified from ChIP-seq. Genomic region around AdamTS9 is
used as negative control. Orange horizontal line represents the
highest ‘‘noise’’ value obtained by ChIP-qPCR on a set of negative
regions. C) Genome browser snapshot for Prdm5 target region
assigned to Dcn gene. Tracks represent IgG, Prdm5-Ab1 and
Prdm5-Ab2 sequencing results as indicated.
(PDF)
Figure S6 Characterization of Prdm5 target genes levels and
osteoblasts markers in Prdm5LacZ/LacZ E16.5 limbs. A) qPCR analysis
for Col1a1 and Col1a2 in E16.5 wild type and Prdm5LacZ/LacZ limbs
(n = 4). * = p,0.05. B) qPCR analysis for Dcn in E16.5 WT and
Prdm5LacZ/LacZ limbs (n = 4). C) Bright field image of picrosirius red
staining in wild type and Prdm5LacZ/LacZ E16.5 tibia. D) In-situ
hybridizations for Spp1/Osteopontin and Ibsp (bar = 400 um) and
immunofluorescence micrographs of Mmp13 (bar = 100 mm),
Vegfa and Osterix (bar = 200 mm) in WT and Prdm5LacZ/LacZ
E16.5 embryo femurs or tibiae. White arrow indicates growth plate
direction for orientation. All histological analyses are performed on
parallel sections between littermate embryos of same sex.
(PDF)
Table S1 Genomic regions identified as high confidence Prdm5
targets from ChIP-seq experiment. Assigned ensembl gene IDs by
annotation are indicated.
(PDF)
Table S2 pQCT parameters measured in wild type and
Prdm5LacZ/LacZ animals at 5 weeks. P-value by T-test is indicated
and cells color-coded according to: yellow = p,0.05, oran-
ge = p,0.01, red = p,0.005.
(PDF)
Table S3 Primers used for qPCR and ChIP-qPCR throughout
the study.
(PDF)
Text S1 Extended description of experimental procedures
including bioinformatics analyses and supplemental references.
(DOCX)
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